We have earlier commented on the sharply accelerated venture capital activity in the biotech sector in China. From around 2-3 deals a month, aggregating maybe USD100m 2-3 years ago, China is now witnessing close to USD1B of venture capital investments in biotech sector on a monthly basis. Keeping company is…
Read More
Furious activity is on around the world to come up with a vaccine for the Covid-19 virus. The stakes are high, not just in human life saving imperative, but also likely financial rewards to the company that is first off the block. The active pipeline, as document by the World…
Read More
The Asian Infrastructure Investment Bank (AIIB) is a new multi-lateral lending institution that came about in Jan 2016. AIIB is a Chinese baby. It was proposed by China; it is headquartered in Beijing. A Chinese, Jin Liqun, is the current President of AIIB. Below him, there are 5 vice presidents,…
Read More
Last weekend there was an interesting news item: A company called Super Plastronics had signed on with French electronic company Thomson to launch its products in India, starting with washing machines. Super Plastronics Pvt Ltd (SPPL) said it would invest Rs 1,000 crore in the next five years to expand…
Read More
After the Galvan incident, where China appears to have encroached into Indian territory, and subsequent confirmed deaths of 20 India soldiers, there are lot of calls in India of reducing imports from China. While as a strategy it may have its merits – you don’t want to depend on imports…
2 comments
An extremely unfortunate event unfolded on Sunday, when established Bollywood movie star Sushant Singh Rajput committed suicide, purportedly from depression. This brought out in stark relief the scourge of mental illness, of which depression is the most common form. That such a successful person, with no monetary problems, can fall…
Read More
Ever since its early years, Reliance Industries Limited (RIL), India’s largest private sector enterprise, has believed in running an active treasury. Beyond supporting business requirements, RIL’s treasury has often taken investment positions, in areas like listed equity. In the ‘80s and ‘90s, it was a fairly commonplace practice amongst listed…
Read More
Earlier this week we wrote how on 2 consecutive months, China’s biotech sector had witnessed more than USD1B of venture capital investment. That chart ignored another source of risk capital – IPOs. China has been producing around 1 biotech IPO a month consistently. These are typically pre-revenue R&D companies, but…
Read More
For the second month in a row, China’s biotech companies attracted more than USD1B of venture capital investment. Biotech investments crossed USD1B for the first time in April’20. Hence, May is the second consecutive month where VC/PE investments in biotech have crossed USD1B. In terms of amout invested, China inching…
Read More